Prostate Cancer Key Statistics
[1]. In contrast, oncemetastasishas been detected by imaging, the vast majority of patients will likely die from prostate cancer. Over the past two decades, serum PSA screening has provided a valuable tool for prostatecancer surveillance, however the age-adjusted incidence of mortality has ...
Statistics on prostate cancer’s natural history suggest that >70% of patients diagnosed after PSA screening are likely to experience an indolent disease course that little impacts their well-being. About 17% of these newly PSA-diagnosed patients, however, will confront an aggressive prostate cancer...
Long-term trends in cancer mortality in the United States, 1930-1998. standard population for the age adjustment of death rates prompted the American Cancer Society to update historical cancer mortality statistics using the new ... PA Wingo,CJ Cardinez,SH Landis,... - 《Cancer》 被引量: 823...
The predictive value of age, race, marital status, and tumor characteristics were compared. The survival of patients with different socioeconomic statuses and bone metastasis statuses was compared by Kaplan–Meier analysis. A total of 1,335 patients with prostate cancer diagnosed between 2009 and ...
Johnny’s PSA was 7,292 on 24 September 2022 (don’t be mistaken, it was 7.2 thousand plus not 7.2). To be “free or cured” of prostate cancer the PSA needs to come down to 6.50 ( yes, 6 point 5 for age 70 and above). When can that happen? Or can that ever happen?
Prognostic multibiomarker signatures in prostate cancer (PCa) may improve patient management and provide a bridge for developing novel therapeutics and imaging methods. Our objective was to evaluate the association between expression of 33 candidate prot
Prostate Cancer Survival Rates by Age The older you get, the more likely you are to develop prostate cancer. Here's how often it's diagnosed among those in different age groups: Under 50: 1 in every 456 Age 50-59: 1 in 54 Age 60-69: 1 in 19 ...
Cancer statistics, 2014. CA Cancer J Clin 2014; 64: 9–29. Article PubMed Google Scholar Masson S, Bahl A . Metastatic castrate-resistant prostate cancer: dawn of a new age of management. BJU Int 2012; 110: 1110–1114. Article PubMed Google Scholar Draisma G, Etzioni R, Tsodikov ...
Prostate cancer and its treatment frequently lead to sexual side effects that negatively impact personal identity, sexual function, and intimate relationships. The sexual consequences of prostate cancer treatment on men who have sex with men (MSM) differ